- Home
- VEEE vs QNRX Comparison
VEEE vs QNRX Comparison
Compare VEEE & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- QNRX
- Stock Information
- Founded
- VEEE 1994
- QNRX 2018
- Country
- VEEE United States
- QNRX United States
- Employees
- VEEE N/A
- QNRX N/A
- Industry
- VEEE Marine Transportation
- QNRX Medical/Dental Instruments
- Sector
- VEEE Industrials
- QNRX Health Care
- Exchange
- VEEE Nasdaq
- QNRX Nasdaq
- Market Cap
- VEEE 6.4M
- QNRX 5.5M
- IPO Year
- VEEE 2021
- QNRX N/A
- Fundamental
- Price
- VEEE $2.35
- QNRX $9.05
- Analyst Decision
- VEEE
- QNRX
- Analyst Count
- VEEE 0
- QNRX 0
- Target Price
- VEEE N/A
- QNRX N/A
- AVG Volume (30 Days)
- VEEE 52.4K
- QNRX 7.2K
- Earning Date
- VEEE 08-13-2025
- QNRX 08-07-2025
- Dividend Yield
- VEEE N/A
- QNRX N/A
- EPS Growth
- VEEE N/A
- QNRX N/A
- EPS
- VEEE N/A
- QNRX N/A
- Revenue
- VEEE $12,724,465.00
- QNRX N/A
- Revenue This Year
- VEEE N/A
- QNRX N/A
- Revenue Next Year
- VEEE N/A
- QNRX N/A
- P/E Ratio
- VEEE N/A
- QNRX N/A
- Revenue Growth
- VEEE N/A
- QNRX N/A
- 52 Week Low
- VEEE $2.05
- QNRX $5.01
- 52 Week High
- VEEE $9.30
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- VEEE 52.35
- QNRX 53.74
- Support Level
- VEEE $2.14
- QNRX $8.60
- Resistance Level
- VEEE $2.28
- QNRX $9.40
- Average True Range (ATR)
- VEEE 0.09
- QNRX 0.48
- MACD
- VEEE 0.03
- QNRX -0.05
- Stochastic Oscillator
- VEEE 80.77
- QNRX 38.17
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.